无晶状体眼的硅油取出与人工晶状体植入

目的探讨玻璃体视网膜手术后无晶状体硅油填充眼的硅油取出联合人工晶状体植入的手术方法与临床效果。方法对无晶状体硅油填充眼行硅油取出联合人工晶状体植入的41例(41眼)进行回顾性研究,其中21眼行前房人工晶状体植入,20眼行后房人工晶状体植入缝线固定术,分别对术前术后的视力和并发症进行比较。结果前房人工晶状体植入术后视力与术前矫正视力基本相同,而缝线固定的后房人工晶状体术后视力稍低于术前矫正视力(P<0.05)。结论无晶状体硅油填充眼硅油取出与人工晶状体植入联合手术临床效果可靠。     

硅油填充并发白内障行超声乳化联合硅油取出及人工晶状体植入术观察

目的 评价硅油填充合并白内障眼经透明角膜切口行白内障超声乳化,联合经瞳孔硅油取出及折叠人工晶状体植入的临床效果.方法 选择硅油填充术后合并白内障患者27只眼,手术方法为经透明角膜切口行白内障超声乳化,然后做3 mm大小的晶状体后囊切开,通过前房灌注,由后囊切开处进行硅油取出,将折叠晶状体植入囊袋内或者睫状沟.评价手术时间、术后反应以及视力恢复效果.结果 手术时间基本控制在20分钟以内,大部分病例折叠人工晶状体植入囊袋内.术后未见视网膜脱离复发、IOL脱位和其他严重并发症,部分病例有不同程度的角膜水肿,患者无明显刺激症状.结论 经透明角膜切口行白内障超声乳化联合经瞳孔区硅油取出并植入折叠人工晶状体,这种方法与经巩膜切口的方法相比,不但减少了手术的时间,而且从理论上也较少了术后并发症和患者的刺激症状,是一种安全高效的硅油取出联合白内障手术方式.     

硅油取出联合白内障摘出人工晶状体植入

目的 探讨硅油填充眼硅油取出联合白内障摘出人工晶状体植入的临床效果.方法 对1999年以来我科14例（14眼）硅油充填眼合并白内障者行硅油取出联合白内障囊外摘出人工晶状体植入,术后随访3～12月.结果 术后视力提高11眼,不变2眼,降低1眼.结论 对眼部状况较好的硅油填充眼,在硅油取出同时行白内障囊外摘出人工晶状体植入可有较好的视力效果.     

玻璃体切除术后无晶状体眼的硅油取出联合人工晶状体植入

0引言对玻璃体切除硅油填充手术后的无晶状体眼,我们通常分期手术,取出硅油后3mo后再植入人工晶状体[1]。分期手术对患者来说增加了一定的经济负担和思想压力,也增加了一定的手术风险。我院对2007-01/2007-10的15例矫正视力≥0.1且眼底视网膜复位较好的无晶状体硅油填充眼行硅油取出与人工晶状体植入联合手术,现将结果报告如下。1临床资料硅油填充眼共15例15眼,男9例9眼,女6例6眼。所有患眼首次行玻璃体视网膜手术硅油填充时已行晶状体切除,硅油取出术前检查视网膜复位良好,无继发青光眼和角膜变性,无明显视神经萎缩。硅油填充原因为眼外伤10眼,复杂性视网膜脱离5眼。手术时间为硅油填充术后3~     

硅油取出联合白内障超声乳化及人工晶状体植入术疗效观察

目的探讨硅油充填眼术后并发性白内障行白内障超声乳化及人工晶体植入联合硅油取出术的临床效果。方法对19例(19只眼)硅油填充术后并发性白内障患者进行经睫状体扁平部切口取硅油联合白内障超声乳化及人工晶状体植入术。结果术后随访3-12个月(平均7个月)。手术后最佳矫正视力光感～眼前指数2只眼,0.02～0.1者4只眼,0.1～0.2者8只眼,0.2以上5只眼。1眼因视网膜脱离复发,经再次手术硅油充填后视网膜复位。1眼术后玻璃体出血,经药物治疗后出血吸收。所有患者均无角膜内皮失代偿、人工晶体移位、硅油残留等。结论硅油取出联合白内障超声乳化及人工晶状体植入术是安全、有效的。严把联合手术的适应症及具备相当的手术技巧是手术成功的关键所在。     

超声乳化联合经后囊硅油取出及人工晶状体植入术

目的 探讨超声乳化联合经后囊硅油取出和人工晶状体植入术治疗硅油填充眼白内障的效果.方法 超声乳化联合经后囊硅油取出和人工晶状体植入术治疗硅油眼合并白内障96例（96眼）.超声乳化吸出术后行后囊环形撕囊,经上方角膜缘切口进入后囊撕囊口取出硅油,植入人工晶状体.结果 术后随访3～6月,所有患者裸眼及矫正视力均较术前提高,人工晶状体居中.3例早期角膜水肿,3～5 d消失,2例视网膜再脱离行再次视网膜复位手术;5例高眼压联合用药后控制正常.结论 对硅油填充眼白内障,行超声乳化联合经后囊硅油取出和人工晶状体植入术,可减少手术次数,并降低手术风险.     

硅油填充术后并发性白内障超声乳化人工晶状体植入术联合硅油取出的临床观察

目的:观察硅油填充术后并发性白内障行超声乳化人工晶状体植入术联合硅油取出的治疗效果。方法:回顾性分析了40例(41只眼)硅油填充术后并发白内障行超声乳化联合硅油取出及人工晶状体植入的病例资料,并随访5~18个月,分析其视力恢复情况及术中、术后并发症。结果:除3例因硅油取出术后视网膜脱离外,其余患者均有不同程度的视力增加。术中主要并发症为后囊膜破裂,术后的主要并发症为视网膜脱离。结论:硅油填充术后并发性白内障行超声乳化人工晶状体植入术联合硅油取出术是一种安全有效的方法。     

硅油取出、白内障超声乳化摘除联合人工晶状体植入术临床观察

目的探讨玻璃体切除硅油填充术后,硅油取出联合白内障超声乳化摘除联合人工晶状体植入的手术方法和临床效果。方法采用标准三通道睫状体平坦部巩膜切口取出硅油联合白内障超声乳化摘除及人工晶状体植入术,对13例(13只眼)硅油填充眼行三联手术治疗,术后随访超过3月。结果三联手术顺利,最佳矫正视力0.04~0.1者3例,0.1~0.5者9例;术后因再次发生视网膜脱离需再次手术治疗者1例;并发症主要有角膜水肿、黄斑囊样水肿、复发性视网膜脱离及后发性白内障。结论硅油取出联合白内障超声乳化摘除及人工晶状体植入是安全有效的方法,既可以减少手术次数、减轻手术损伤,同时还可以减轻患者的经济负担,能有效提高患者的视力。     

硅油充填眼行白内障超声乳化人工晶状体植入联合硅油取出术

目的 探讨玻璃体切割术后硅油充填眼经透明角膜切口行白内障超声乳化摘除、硅油取出、人工晶状体植入联合手术(1组)以及经睫状体平坦部置灌注管行白内障超声乳化摘除、硅油取出、人工晶状体植人(2组)两种手术方式的临床疗效观察。方法 对2000年1月～2003年4月间玻璃体切割术后硅油充填眼白内障患者78例(78只眼)经透明角膜行联合手术。对49例(49只眼)经睫状体平坦部行联合手术。观察眼底视网膜复位良好，行人工晶状体植入术。结果 1组病例有中52只眼最佳矫正视力达0.1～0.6(66．67％)；19只眼视力为0.02～0.1(24．36％)；7只眼视力为光感～指数(8．97％，包括5只眼视网膜脱离复发者)。2组病例中31只眼最佳矫正视力达0.1～0.6(65．3％)；11只眼视力为0.02～0.1(22．45％)；7只眼视力为光感～指数(14．3％，包括2只眼视网膜脱离复发者)。2组病例中有1只眼出现睫状体平坦部切口渗血，所有病例均无持续性角膜内皮失代偿、硅油泡残留、人工晶状体移位等并发症发生。结论 硅油眼行白内障超声乳化、硅油取出、人工晶状体植入术对于玻璃体切除手术后硅油充填眼并发白内障是一种安全、有效的方法。经透明角膜切口行此手术简化了手术步骤，减少了手术并发症的发生。     

硅油取出联合白内障超声乳化及人工晶状体植入术

目的:探讨硅油充填眼并发性白内障行硅油取出联合白内障超声乳化及人工晶状体植入术的临床效果。方法:对25例25眼硅油填充术后并发性白内障患者进行经睫状体扁平部切口取硅油联合白内障超声乳化及人工晶状体植入术。结果:术后随访3～12(平均7)mo。手术后最佳矫正视力:光感～指数/眼数者3眼,0.02～0.1者4眼,0.1～0.2者10眼,>0.2者8眼。所有患者均无持续性角膜内皮失代偿、硅油泡残留、人工晶状体移位、玻璃体出血等并发症。结论:硅油取出联合白内障超声乳化及人工晶状体植入术是安全、有效的。     

硅油填充眼并发性白内障的手术疗效观察

目的：观察玻璃体切割术后硅油填充眼并发白内障行超声乳化联合硅油取出及人工晶状体植入术的临床效果及安全性。方法：对32例32眼硅油填充术后并发白内障患者行超声乳化联合经睫状体平坦部切口取硅油及折叠式人工晶状体植入术。术后随访3～18（平均9）mo。结果：术后最佳矫正视力：光感～数指/眼前者3眼,0.02～0.1者10眼,〉0.1～0.2者12眼,≥0.3者7眼。所有患者均无视网膜脱离、角膜内皮失代偿、人工晶状体移位或硅油残留等。结论：白内障行超声乳化联合硅油取出及折叠式人工晶状体植入术治疗硅油填充眼并发性白内障安全、有效。     

Phacoemulsification combined with transpupillary removal of silicone oil and intracapsular intraocular lens implantation

AIM: To estimate the effectiveness of phacoemulsification and foldable intraocular lens (IOL) implantation combined with transpupillary silicone oil removal. METHODS: There were 168 eyes of 168 candidate patients with cataract and silicone oil-filled eyes recruited in our study. All of the patients received the intraocular silicone oil removal surgery by transpupillary drainage and cataract extraction by phacoemulsi?cation. Then the IOL implantation were also performed through corneal incision. RESULTS: The surgery was successfully completed in all eyes. Best corrected visual acuity (BCVA) and postoperative complications were recorded in three months after surgery. There were 143 eyes with BCVA improved, otherwise 25 eyes remained stable at the last follow-up visit. The mean BCVA statistically improved from 20/400±0.02 to 20/100±0.15 (P<0.001) and mean postoperative IOP was 13.85±2.18 mm Hg (P=0.415). No intra-operative complications were reported. CONCLUSION: Phacoemulsi?cation combined with transpupillary removal of silicone oil is a safe and simple effective method. In general, it enables quick recovery of visual acuity with less complication rate.     

Phacoemulsification and foldable intraocular lens implantation combined with vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy

PURPOSE: To determine the clinical outcomes of phacoemulsification and foldable intraocular lens (IOL) implantation combined with primary vitrectomy and silicone oil tamponade to treat severe proliferative diabetic retinopathy (PDR). SETTING: Department of Ophthalmology, Seoul National University College of Medicine, and Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea. METHODS: The results of combined cataract surgery and silicone oil injection in 20 eyes (20 patients) were retrospectively analyzed. All patients had tractional or tractional-rhegmatogenous retinal detachment and clinically significant lens opacities; none had previous intraocular surgery. An acrylic foldable IOL was implanted in the capsular bag or ciliary sulcus. RESULTS: Primary anatomic success was achieved in 90% of eyes. Functional success was attained in 60% of eyes after a mean follow-up of 7.6 months. The postoperative visual acuity improved in 60% of patients, was unchanged in 20%, and was worse in 20%. Silicone oil was removed in 80% of patients without complications after a mean of 3.4 months. The mean absolute value of the difference between the predicted refraction and postoperative refraction was 0.74 diopter (D) (range 0.03 to 1.74 D). CONCLUSION: Phacoemulsification and foldable IOL implantation combined with primary vitrectomy and silicone oil tamponade was performed safely with favorable anatomic and visual outcomes in eyes with severe PDR.     

硅油填充眼在不同时机行人工晶状体植入的屈光误差比较

目的:比较玻璃体切割硅油填充眼不同时机行白内障超声乳化并人工晶状体植入术后屈光误差。方法:回顾性分析选取2009-01/2011-12玻璃体切割硅油填充眼不同时机行白内障超声乳化并人工晶状体植入术51例51眼,其中A组17例行玻璃体切割硅油填充联合白内障超声乳化并人工晶状体植入术,术后3～6mo行硅油取出;B组13例行玻璃体切割术后硅油取出联合白内障超声乳化并人工晶状体植入术,C组21例硅油取出术后择期行白内障超声乳化并人工晶状体植入术,比较术后3mo时屈光误差情况。结果:三组平均绝对屈光误差值分别为(0.873±0.256)D,(0.828±0.134)D,(0.473±0.121)D,A组和B组之间差异无统计学意义(P>0.05),C组和A组及B组之间差异有统计学意义(P<0.05)。结论:A超眼轴测量计算人工晶状体度数,玻璃体切割硅油填充眼在取油后择期行白内障超声乳化并人工晶状体植入术屈光误差小。     

Application of Foldable Intraocular Lens in Multiple Types of Cataract

Objestive:To evaluate the clinical results of implantation of foldable intraocular lens in multiple types of cataract.Methods:This retrospective study comprised 162 eyes of 148 patients undergoing phacoemulsification and implantation of foldable intraocular lens,some of whom underwent combined pars plana vitrectomy or trabeculectomy of silicone oil removal.The period of follow-up was from 3 months to 17 months.Results:There is slight reaction postoperatively in all cases.The postoperative uncorrected visual acuite was from 0.05 to 1.2,patient with 0.6 or above acuity were 70.98%,A neodymium:YAG capsulotomy was required in 5eyes.Posterior capsule ruptured in 1 eyes,and a PMMA intraocular lens was implanted in ciliary sulcus.In one eye,a lens was removed because of recurrence of retina detachment.Conclusions:The application of foldable intraocular lens in multiple types of cataract is safe,and there is a slight postoperative reaction less complications,and fast visual asuity recovery.     

玻璃体切除联合白内障手术治疗增生性糖尿病视网膜病变的临床效果

目的观察玻璃体切除硅油填充术联合超声乳化白内障摘除人工晶状体植入术治疗增生性糖尿病视网膜病变的临床疗效。方法根据患者自愿原则,将53例（57只眼）增生性糖尿病视网膜病变Ⅵ期患者分成联合手术组和玻璃体手术组。联合手术组33例（33只眼）,单纯玻璃体手术组20例（24只眼）。联合手术组进行玻璃体视网膜手术、硅油填充、超声乳化白内障摘除及折叠型人工晶状体植入术,单纯玻璃体手术组进行玻璃体视网膜手术及硅油填充。对两组术后视网膜复位情况和并发症进行对照分析。结果联合手术组视网膜完全复位29只眼,视网膜复位率为87．9％;单纯玻璃体手术组视网膜完全复位20只眼,视网膜复位率为83．3％,两组比较差异无统计学意义（P=0．626）。联合手术组发生虹膜新生血管1只眼（3．0％）,单纯玻璃体手术组发生虹膜新生血管2只眼（8．3％）。均发生在视网膜未复位的患者,两组比较差异无统计学意义（P=0．775）。结论玻璃体视网膜手术联合超声乳化白内障摘除人工晶状体植入术治疗增生性糖尿病视网膜病变安全有效,联合手术可避免再次行白内障手术。     

Phacoemulsification with transpupillary silicone oil removal and lens implantation through a corneal incision using topical anesthesia

PURPOSE: To evaluate phacoemulsification combined with transpupillary silicone oil removal and foldable intraocular lens (IOL) implantation through a single corneal incision and planned posterior capsulorhexis after pars plana vitrectomy using topical anesthesia. SETTING: Department of Ophthalmology, University of Bari, Bari, Italy. METHODS: This noncomparative nonrandomized noncontrolled interventional case series comprised 34 consecutive patients (34 eyes). The mean age of the 25 men and 9 women was 54.4 years +/- 13.3 (SD). A mean of 8.2 +/- 9.4 months after silicone oil injection, patients had phacoemulsification with transpupillary silicone oil removal and foldable acrylic IOL implantation through a single corneal incision and a planned posterior capsulorhexis under topical anesthesia. Patients were operated on by the same surgeon. Visual acuity, the frequency of retinal redetachment, secondary cataract and vitreous hemorrhage formation, subjective pain and discomfort, the duration of surgery, and intraocular pressure (IOP) were noted. The mean follow-up was 9.4 +/- 5.1 months (range 4 to 21 months). RESULTS: Vision improved or stabilized in 88.2% of eyes. Retinal redetachment occurred in 4 eyes (11.8%) and transient vitreous hemorrhage in 1 (2.9%). All patients reported minimal discomfort during the procedure. The mean duration of surgery was 17 +/- 4 minutes. There was no significant intraoperative or postoperative IOP variation. CONCLUSIONS: Combined phacoemulsification, transpupillary silicone oil removal, and IOL implantation through a single corneal incision under topical anesthesia was safe and effective. In general, the visual outcomes were good with improvement in visual acuity.     

Topical anesthesia for transpupillary silicone oil removal combined with cataract surgery

PURPOSE: To assess safety of topical anesthesia for transpupillary silicone oil removal in combination with cataract surgery. SETTING: Department of Ophthalmology Mannheim, University of Heidelberg, Mannheim, Germany. METHODS: The clinical interventional study included 37 consecutive patients having transpupillary silicone oil removal combined with cataract surgery. Without exception, surgery was carried out in topical anesthesia for all patients. During the study period, there were no patients having transpupillary silicone oil removal in another type of local anesthesia than topical anesthesia. Topical anesthesia was achieved with oxybuprocaine 0.4% eyedrops installed 4 to 5 times prior to surgery. Cataract surgery was performed using the clear cornea technique with implantation of a foldable intraocular posterior chamber lens. Silicone oil was released through a planned posterior capsulotomy during cataract surgery prior to implantation of the intraocular lens (IOL). RESULTS: For all patients, surgery could be carried out in topical anesthesia without switching to peribulbar or any other type of anesthesia. None of the patients complained about severe pain intraoperatively or postoperatively. No severe complications such as expulsive hemorrhage, luxation of the IOL, or iris incarceration were encountered in any of the surgeries. CONCLUSION: Transpupillary silicone oil through a planned posterior capsulotomy during cataract surgery may be performed in topical surgery.     

Refractive outcome of silicone oil removal and intraocular lens implantation using laser interferometry

PURPOSE: To evaluate the refractive outcome of silicone oil removal and intraocular lens (IOL) implantation using laser interferometry. METHODS: Thirteen silicone oil-filled eyes of 12 patients were included in the study. IOL power calculation was performed using laser interferometry (IOLMaster V1.1; Carl Zeiss, Jena, Germany). All of these eyes underwent silicone oil removal and cataract extraction with IOL implantation. Post-operative refraction was evaluated. RESULTS: The mean deviation of the final post-operative refraction (spherical equivalent) was -0.30+/-0.91 D (range, -1.87 to +1.3) at 12 weeks. The mean axial length of the eyes was 22.99+/-0.84 mm (range, 22.07-25.24 mm). No major complications occurred intra- or post-operatively. CONCLUSION: Laser interferometry appears to be a feasible and satisfactorily accurate method to calculate IOL power in some silicone oil-filled eyes. Further studies comparing this technique to others are warranted.